NCT01034839View on ClinicalTrials.gov

High-dose Cytarabine and Survival in AML

CompletedOBSERVATIONAL
Enrollment

499

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2009

Conditions
Acute Myeloid Leukemia
Trial Locations (1)

05430010

University of Sao Paulo, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT01034839 - High-dose Cytarabine and Survival in AML | Biotech Hunter | Biotech Hunter